Journal of Clinical Endocrinology & Metabolism, Vol 80, 3273-3278, Copyright © 1995 by Endocrine Society

ARTICLES

Opposing actions of transforming growth factor-beta and glucocorticoids in the regulation of fibronectin expression in the human placenta

S Guller, R Wozniak, L Kong and CJ Lockwood
Department of Obstetrics/Gynecology and Reproductive Science, Mount Sinai Medical Center, New York, New York 10029, USA.

Alterations in the expression of extracellular matrix (ECM) proteins in the placenta and fetal membranes have been linked to parturition whether occurring before or at term. In the present study, we examined the individual and combined effects of transforming growth factor (TGF)- beta and dexamethasone (DEX) on the expression of oncofetal fibronectin (onfFN), i.e. a major ECM protein synthesized by placenta, in cytotrophoblasts isolated from human term placentas to establish a model system from which to evaluate the actions of positive and negative regulators of ECM protein expression in the human placenta. Cytotrophoblasts were maintained for 21=62 h in medium supplemented with 4% charcoal-stripped calf serum in the presence or absence of TGF- beta (2 ng/mL) and DEX (10(-7) mol/L). Levels of onfFN in culture media were determined by immunoassay. TGF-beta treatment alone induced approximately a 150% increase in media levels of onfFN after 21 and 45 h of culture when compared with control, whereas DEX treatment alone reduced levels of onfFN to 15% of control levels. Media levels of onfFN in cells treated with both TGF-beta and DEX were 40-90% of control levels. Similarly, treatment of cells with TGF-beta alone promoted a 100-250% increase in rates of FN synthesis and levels of FN messenger ribonucleic acid, whereas DEX treatment alone reduced these indices of FN expression to approximately 10% of control levels. In cells treated with TGF-beta and DEX, levels of ECM protein synthesis and FN messenger ribonucleic acid were between 30 and 100% of control values. Similar patterns of regulation of FN expression by TGF-beta and DEX were observed when experiments were carried out in serum-free medium. Our results suggest that during pregnancy, TGF-beta and glucocorticoids may be important opposing physiological regulators of placental ECM protein expression.

This article has been cited by other articles:

				A. E. Michael and A. T. Papageorghiou Potential significance of physiological and pharmacological glucocorticoids in early pregnancy Hum. Reprod. Update, September 1, 2008; 14(5): 497 - 517. [Abstract] [Full Text] [PDF]

				K. Y Arai and T. Nishiyama Developmental Changes in Extracellular Matrix Messenger RNAs in the Mouse Placenta During the Second Half of Pregnancy: Possible Factors Involved in the Regulation of Placental Extracellular Matrix Expression Biol Reprod, December 1, 2007; 77(6): 923 - 933. [Abstract] [Full Text] [PDF]

				G. Li, J. H. Heaton, and T. D. Gelehrter Role of Steroid Receptor Coactivators in Glucocorticoid and Transforming Growth Factor {beta} Regulation of Plasminogen Activator Inhibitor Gene Expression Mol. Endocrinol., May 1, 2006; 20(5): 1025 - 1034. [Abstract] [Full Text] [PDF]

				M.-J. Lee, Y. Ma, L. LaChapelle, S. S. Kadner, and S. Guller Glucocorticoid Enhances Transforming Growth Factor-{beta} Effects on Extracellular Matrix Protein Expression in Human Placental Mesenchymal Cells Biol Reprod, May 1, 2004; 70(5): 1246 - 1252. [Abstract] [Full Text] [PDF]

				G. Li, S. Wang, and T. D. Gelehrter Identification of Glucocorticoid Receptor Domains Involved in Transrepression of Transforming Growth Factor-{beta} Action J. Biol. Chem., October 24, 2003; 278(43): 41779 - 41788. [Abstract] [Full Text] [PDF]

				C.-Z. Song, X. Tian, and T. D. Gelehrter Glucocorticoid receptor inhibits transforming growth factor-beta signaling by directly targeting the transcriptional activation function of Smad3 PNAS, October 12, 1999; 96(21): 11776 - 11781. [Abstract] [Full Text] [PDF]

				J. S. Ryu, R. J. Majeska, Y. Ma, L. LaChapelle, and S. Guller Steroid Regulation of Human Placental Integrins: Suppression of {alpha}2 Integrin Expression in Cytotrophoblasts by Glucocorticoids Endocrinology, September 1, 1999; 140(9): 3904 - 3908. [Abstract] [Full Text]

				T. Hahn, S. Barth, R. Graf, M. Engelmann, D. Beslagic, J. M. H. M. Reul, F. Holsboer, G. Dohr, and G. Desoye Placental Glucose Transporter Expression Is Regulated by Glucocorticoids J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1445 - 1452. [Abstract] [Full Text]

				R. A. Nowak, F. Haimovici, J. D. Biggers, and G. T. Erbach Transforming Growth Factor-ß Stimulates Mouse Blastocyst Outgrowth through a Mechanism Involving Parathyroid Hormone-Related Protein Biol Reprod, January 1, 1999; 60(1): 85 - 93. [Abstract] [Full Text]

				D. Y. Yoon, Y. Ma, G. Krikun, C. J. Lockwood, L. LaChapelle, and S. Guller Glucocorticoid Effects in the Human Placenta: Evidence That Dexamethasone-Mediated Inhibition of Fibronectin Expression in Cytotrophoblasts Involves a Protein Intermediate J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 632 - 637. [Abstract] [Full Text]